Log In
Print
BCIQ
Print
Print this Print this
 

ANB004

  Manage Alerts
Collapse Summary General Information
Company AnaptysBio Inc.
DescriptionMAb against Interleukin-17 (IL-17)
Molecular Target Interleukin-17 (IL-17)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today